Table 2 Demographic characteristics of the study population
Total n (%) | Bacterial coinfection (n) | Without bacterial coinfection (n) | |
|---|---|---|---|
Study patients (n) | 28 (100) | 7 | 21 |
Male | 17 (60.7) | 5 | 12 |
Age (years) median [ICR] | 62 [50 to 76] | 62 [61 to 83] | 62 [48 to 75] |
Comorbidities | |||
COPD | 3 (10.7) | 1 | 2 |
Asthma | 3 (10.7) | 0 | 3 |
Heart failure | 2 (7.1) | 1 | 1 |
Alcoholism | 3 (10.7) | 0 | 3 |
Immunosuppression | 7 (25.0) | 2 | 5 |
No comorbidities | 11 (39.3) | 3 | 8 |
Clinical manifestations | |||
Fever | 19 (67.9) | 6 | 13 |
Cough | 25 (89.3) | 6 | 19 |
Purulent secretions | 19 (67.9) | 5 | 14 |
Dyspnea | 20 (71.4) | 5 | 15 |
Radiologic pattern | |||
Alveolar | 15 (53.6) | 6 | 9 |
Interstitial | 3 (10.7) | 1 | 2 |
Interstitial alveolar | 10 (35.7) | 0 | 10 |
Bilateral | 17 (60.7) | 2 | 15 |
Pleural effusion | 8 (28.6) | 2 | 6 |
Complete blood count | |||
Leukopenia/leukocytosis/mm3 (< 4000 year > 11,000) | 16 (57.1) | 4 | 12 |
Thrombocytopenia/mm3 (< 150,000) | 9 (32.1) | 4 | 5 |
Lymphopenia/mm3 (< 1000) | 23 (82.1) | 6 | 17 |